Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 1, 1996, Pages 68-74

  Li, Jin S ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Antihypertensive therapy; Calcium channel antagonist; Cilazapril; Hypertension; Mibefradil; Remodeling; Resistance arteries; Vascular hypertrophy

Indexed keywords

CALCIUM CHANNEL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MIBEFRADIL;

ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HYPERTENSION; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RESISTANCE BLOOD VESSEL; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RESISTANCE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZIMIDAZOLES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CILAZAPRIL; CORONARY VESSELS; FEMORAL ARTERY; HEART; HYPERTENSION; MESENTERIC ARTERIES; MIBEFRADIL; MICROCIRCULATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RENAL ARTERY; RENIN; TETRAHYDRONAPHTHALENES;

EID: 0029994297     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199607000-00011     Document Type: Article

References (26)

1. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and in increased number of smooth muscle cell layers. Circ Res 1978;43:854-64.
2. Mulvany MJ, Korsgaard N. Correlations and otherwise between blood pressure, cardiac mass and resistance vessel characteristics in hypertensive, normotensive and hypertensive/normotensive hybrid rats. J Hypertens 1983;1:235-44.
3. Mulvany MJ, Baandrup U, Gundersen HJG. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a 3-dimensional dissector. Circ Res 1985;57:794-800.
4. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989;13:968-72.
5. Deng LY, Schiffrin EL. Effects of endothelin-1 and vasopressin on small arteries of spontaneously hypertensive rats. Am J Hypertens 1992;5:817-22.
6. Li J-S, Schiffrin EL. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 1995;25(Part 1):495-500.
7. Izzard AS, Heagerty AM. Hypertension and the vasculature: arterioles and the myogenic response. J Hypertens 1995;13:1-4.
8. Christensen KL, Jespersen LT, Mulvany MJ. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens 1989;7:83-90.
9. Harrap SB, Van der Merwe WM, Griffin SA, McPherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure longterm. Hypertension 1990;16:603-14.
10. Mulvany MJ, Persson AEG, Andresen J. No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure. J Hypertens 1991;9:589-93.
11. Lee RMKW, Berecek KH, Tsoporis J, McKenzie R, Triggle CR. Prevention of hypertension and vascular changes by captopril treatment. Hypertension 1991;17:141-50.
12. Hajdu MA, Heistad DD, Baumbach GL. Effects of antihypertensive therapy on mechanics of cerebral arterioles in rats. Hypertension 1991;17:308-16.
13. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension 1994;23: 659-66.
14. 2+ channel blocker with potent vasodilator but weak inotropic action. J Cardiovasc Pharmacol 1989;13:754-9.
15. 2+ channels by Ro 40-5967. Circ Res 1994;75:144-8.
16. Li J-S, Schiffrin EL. Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats. J Hypertens 1995;13:647-52.
17. Li JS, Larivière R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in DOCA-salt hypertensive rats. Hypertension 1994;24:183-8.
18. Deng LY, Schiffrin EL. Effects of endothelin on small arteries of DOCA-salt hypertensive rats. Am J Physiol 1992; 262:H1782-7.
19. Clozel J-P, Kuhn H, Hefti F. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J Hypertens 1989;7:267-75.
20. Griffin SA, Brown WCB, Macpherson F, et al. Angiotensin II causes vascular hyertrophy in part by a non-pressor mechanism. Hypertension 1991;17:626-35.
21. 1 expression determines growth response to angiotensin II. J Clin Invest 1992;90:456-61.
22. 2+ responses to angiotensin II but not to endothelin-1. J Hypertens 1994;12:663-73.
23. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25(Part 1):474-81.
24. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994;23:83-91.
25. Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor: comparison with effects of a beta blocker. Am J Hypertens 1995;8:229-36.
26. Brush JE, Cannon RO, Schenke WH, et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988;319:1302-7.